AAAAAA

   
Results: 1-15 |
Results: 15
One week terbinafine 1% cream (Lamisil (R)) once daily is effective in thetreatment of interdigital tinea pedis: a vehicle controlled study
Authors: Korting, HC Tietz, HJ Brautigam, M Mayser, P Rapatz, G Paul, C
Citation: Hc. Korting et al., One week terbinafine 1% cream (Lamisil (R)) once daily is effective in thetreatment of interdigital tinea pedis: a vehicle controlled study, MED MYCOL, 39(4), 2001, pp. 335-340
Formoterol monotherapy compared with combined ipratropium bromide plus fenoterol in the treatment of chronic obstructive pulmonary disease
Authors: Konermann, M Suchantke, R Mogck, J Brauburger, J Brautigam, M
Citation: M. Konermann et al., Formoterol monotherapy compared with combined ipratropium bromide plus fenoterol in the treatment of chronic obstructive pulmonary disease, CLIN DRUG I, 21(4), 2001, pp. 235-242
Effect of low-dose cyclosporin A microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severepediatric atopic dermatitis
Authors: Bunikowski, R Gerhold, K Brautigam, M Hamelmann, E Renz, H Wahn, U
Citation: R. Bunikowski et al., Effect of low-dose cyclosporin A microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severepediatric atopic dermatitis, INT A AL IM, 125(4), 2001, pp. 344-348
Low-dose cyclosporin A microemulsion in children with severe atopic dermatitis: Clinical and immunological effects
Authors: Bunikowski, R Staab, D Kussebi, F Brautigam, M Weidinger, G Renz, H Wahn, U
Citation: R. Bunikowski et al., Low-dose cyclosporin A microemulsion in children with severe atopic dermatitis: Clinical and immunological effects, PEDIAT A IM, 12(4), 2001, pp. 216-223
A human B-cell CLL model established by transplantation of JOK-1 cells into SCID mice and an anti-leukemia efficacy of fludarabine phosphate
Authors: Bai, LY Kon, K Tatsumi, M Ito, H Hayashi, S Brautigam, M
Citation: Ly. Bai et al., A human B-cell CLL model established by transplantation of JOK-1 cells into SCID mice and an anti-leukemia efficacy of fludarabine phosphate, ONCOL REP, 7(1), 2000, pp. 33-38
A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life
Authors: Czech, W Brautigam, M Weidinger, G Schopf, E
Citation: W. Czech et al., A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life, J AM ACAD D, 42(4), 2000, pp. 653-659
Steroidal sigma receptor ligands affect signaling pathways in human spermatozoa
Authors: Schaefer, M Habenicht, UF Brautigam, M Gudermann, T
Citation: M. Schaefer et al., Steroidal sigma receptor ligands affect signaling pathways in human spermatozoa, BIOL REPROD, 63(1), 2000, pp. 57-63
Efficacy and tolerability of terbinafine 1% topical solution used for 1 week compared with 4 weeks clotrimazole 1% topical solution in the treatment of interdigital tinea pedis: a randomized, double-blind, multi-centre, 8-week clinical trial
Authors: Schopf, R Hettler, O Brautigam, M Weidinger, G Kaben, U Mayser, P Resl, V
Citation: R. Schopf et al., Efficacy and tolerability of terbinafine 1% topical solution used for 1 week compared with 4 weeks clotrimazole 1% topical solution in the treatment of interdigital tinea pedis: a randomized, double-blind, multi-centre, 8-week clinical trial, MYCOSES, 42(5-6), 1999, pp. 415-420
Post-stroke treatment with imidapril reduces learning deficits with less formation of brain oedema in a stroke-prone substrain of spontaneously hypertensive rats
Authors: Yabuuchi, F Takahashi, M Aritake, K Fujimoto, M Ito, H Tsuzaki, M Akai, T Yamaguchi, M Hayashi, S Nishino, Y Brautigam, M
Citation: F. Yabuuchi et al., Post-stroke treatment with imidapril reduces learning deficits with less formation of brain oedema in a stroke-prone substrain of spontaneously hypertensive rats, FUN CL PHAR, 13(4), 1999, pp. 475-483
In vivo kinetics of microbubbles of SHU 508 A (Levovist((R))): Comparison with Indocyanine Green in rabbits
Authors: Uchimoto, R Niwa, K Eguchi, H Kamiyama, N Mine, Y Miyazawa, T Brautigam, M
Citation: R. Uchimoto et al., In vivo kinetics of microbubbles of SHU 508 A (Levovist((R))): Comparison with Indocyanine Green in rabbits, ULTRASOUN M, 25(9), 1999, pp. 1365-1370
Dose-dependency and rate of decay of efficacy of Resovist on MR images in a rat cirrhotic liver model
Authors: Kato, N Takahashi, M Tsuji, T Ihara, S Brautigam, M Miyazawa, T
Citation: N. Kato et al., Dose-dependency and rate of decay of efficacy of Resovist on MR images in a rat cirrhotic liver model, INV RADIOL, 34(9), 1999, pp. 551-557
Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species
Authors: Hamm, H Schwinn, A Brautigam, M Weidinger, G
Citation: H. Hamm et al., Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species, BR J DERM, 140(3), 1999, pp. 480-482
Eosinophils, pruritus and psoriasis: effects of treatment with etretinate or cyclosporin-A
Authors: Schopf, RE Hultsch, T Lotz, J Brautigam, M
Citation: Re. Schopf et al., Eosinophils, pruritus and psoriasis: effects of treatment with etretinate or cyclosporin-A, J EUR A D V, 11(3), 1998, pp. 234-239
Mechanisms responsible for resistance of sublines derived from leukemia cell lines to an antitumer agent 9-beta-D-arabinofuranosyl-2-fluoroadenine (vol 124, pg 367, 1998)
Authors: Bai, LY Yamaguchi, M Tatsumi, M Kon, K Brautigam, M
Citation: Ly. Bai et al., Mechanisms responsible for resistance of sublines derived from leukemia cell lines to an antitumer agent 9-beta-D-arabinofuranosyl-2-fluoroadenine (vol 124, pg 367, 1998), J CANC RES, 124(11), 1998, pp. 641-641
The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis whenused topically under occlusion
Authors: Mrowietz, U Graeber, M Brautigam, M Thurston, M Wagenaar, A Weidinger, G Christophers, E
Citation: U. Mrowietz et al., The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis whenused topically under occlusion, BR J DERM, 139(6), 1998, pp. 992-996
Risultati: 1-15 |